Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients

prnasiaDecember 02, 2021

Tag: Kintor Pharma , KX-826 , AGA , Male Alopecia

PharmaSources Customer Service